Weil-Haltingen, Germany

Jeurgen Klaus Maibaum

USPTO Granted Patents = 6 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
6 patents (USPTO):

Title: Innovator Spotlight: Jeurgen Klaus Maibaum

Introduction

Jeurgen Klaus Maibaum, located in Weil-Haltingen, Germany, is a distinguished inventor recognized for his contributions to the field of pharmaceuticals. With a remarkable portfolio that includes six patents, Maibaum has made significant strides in developing innovative therapeutic solutions.

Latest Patents

Among his latest patents is a groundbreaking invention related to complement pathway modulators and their therapeutic applications. The patent presents a compound of formula I, detailing the methods for manufacturing these compounds and their various uses in the medical field. It also encompasses a combination of pharmacologically active agents along with a comprehensive pharmaceutical composition. This innovation aims to enhance therapeutic strategies and provide effective treatment options for various health conditions.

Career Highlights

Throughout his career, Maibaum has shown exceptional ingenuity and commitment to advancing medical science. His work at Novartis AG has positioned him as a key player in pharmaceutical innovation, focusing on developing solutions that address complex health challenges. His contributions to the organization highlight his expertise and determination to push the boundaries of what is possible in drug development.

Collaborations

Jeurgen Klaus Maibaum collaborates with talented professionals in his field, including esteemed colleagues Ulrich Hommel and Edwige Liliane Jeanne Lorthiois. Together, they contribute to a dynamic and innovative environment within Novartis AG, fostering the development of novel therapeutic agents that have the potential to significantly impact patient care.

Conclusion

Jeurgen Klaus Maibaum's inventive spirit and dedication to pharmaceutical advancements make him a noteworthy figure in the realm of medical innovation. His patents not only exemplify his expertise but also represent the collective efforts within Novartis AG to improve healthcare solutions. As innovations such as those pioneered by Maibaum continue to emerge, the future of therapeutic applications stands to benefit greatly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…